(Q43761926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

J Isaacsohn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W Insull

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E Stein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Kwiterovich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M A Patrick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Brazg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C A Dujovne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Shan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E Shugrue-Crowley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Ripa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Tota

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Cerivastatin Study Group

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

1 reference

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

IV1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting

12 November 2019

cites work

1 reference

12 December 2020

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia

1 reference

12 December 2020

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

1 reference

12 December 2020

Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patients with nephrotic syndrome

1 reference

12 December 2020

The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial

1 reference

12 December 2020

Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group

1 reference

12 December 2020

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

12 December 2020

Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group

1 reference

12 December 2020

Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins.

1 reference

12 December 2020

Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

1 reference

12 December 2020

Effect of simvastatin on Lp(a) concentrations

1 reference

12 December 2020

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

1 reference

12 December 2020

Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group

1 reference

12 December 2020

Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies

1 reference

12 December 2020

Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety

1 reference

12 December 2020

Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor

1 reference

12 December 2020

Assessing the benefits of lipid-lowering therapy.

1 reference

12 December 2020

Cerivastatin in primary hyperlipidemia--a multicenter analysis of efficacy and safety

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960240902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11594407%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

11594407

1 reference